The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma
Open Access
- 15 October 1995
- Vol. 76 (8), 1440-1444
- https://doi.org/10.1002/1097-0142(19951015)76:8<1440::aid-cncr2820760822>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinomaUrology, 1993
- Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerCancer, 1992
- Nuclear morphometry in prognosis of renal adenocarcinomaUrology, 1992
- Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinomaUrology, 1992
- The prognostic significance of selective nuclear morphometry in urinary bladder carcinomaHuman Pathology, 1990
- Renal carcinoma.Reevaluation of prognostic factorsCancer, 1988
- Nuclear morphometry as an important prognostic factor in stage I renal cell carcinomaCancer, 1986
- Renal cell carcinoma: Survival and prognostic factorsUrology, 1986
- The Surgical Management of Renal Cell CarcinomaJournal of Urology, 1972
- Renal cell carcinoma.Natural history and results of treatmentCancer, 1970